IN FOCUS FEATURE
Scientists, Companies Benefit in New Statewide Fellowship Program
FROM OUR WEB SITE
 |
In Focus
Scientists, Companies Benefit in New Statewide Fellowship Program
The NCBC Industrial Fellowship Program is designed to help postdoctoral scientists from the state's research universities transition into industry R&D careers. In the process, it will retain home-grown research talent by providing work experience in North Carolina's life-science companies. It is designed to fill a gap for scientists in need of industry experience as well as for companies in need of scientific expertise.
In this week's In Focus, read about the new Industrial Fellowship program and how it will benefit North Carolina.
From Our Web Site
Feds Give NC $1.6M Jobs Grant
NC Commerce wins $1.6M fed grant to help at-risk or jobless to start their own small businesses.
Addrenex May Get $27M More
Drug development pact could bring Morrisville's Addrenex an additional $27 million.
Biotech Center Fellowships Link Academic Scientists, Industry
The North Carolina Biotechnology Center launched a new fellowship program to help academic scientists move into the state's life science companies.
Drug Maker Coming to Lenoir
Galexe Pharma Sciences, a subsidiary of Virginia-based Excela PharmSci Inc., plans to open a pharmaceutical manufacturing plant in Caldwell County.
RTI Helps FDA Plan Food Tests
RTI International applies science to help the FDA assess food-safety risks.
CoLucid Catches $25M Boost
Durham-based CoLucid closes on a $25 million Series B round of funding.
DuPont Lauds Duke, UNC Profs
Young professors at Duke, UNC win cash and kudos in international DuPont grant program.
Salix Tests New IBS Drug
Salix initiates Phase 3 trial for rifaximin in IBS patients.
BioMarck Tests COPD Drug
NCSU spin-out BioMarck to enter Phase 2 trial of its lead therapy for COPD.
UNC Gets $3.4M EPA Grant
EPA gives UNC computational toxicology sleuths $3.4M to find genetic predictors of toxic effects.
News from Other Sites
Algae Has Potential to be a Green Power
Scientists at Brunswick Community College are growing 6,000 liters of algae in a number of large glass tubes that they hope to convert into biodiesel.
From Myrtle Beach Sun-News
Cancer Cure in Mice to Get Human Trials
Clinical trials begin this week at Wake Forest University on a cancer therapy that has completely cured the disease in every mouse tested over the past few years.
From the (Raleigh) News & Observer
CoLucid Ready on Migraine Drug
The drug development company has raised $25 million in financing to launch the final phase of testing of its experimental migraine treatment.
From the (Raleigh) News & Observer
Coming Home
N&O Columnist Dennis Rogers and his wife, HollyAnn, took an RV trip around the country over the past year. The trip recently ending when HollyAnn was called to work for the BioFuels Center of North Carolina. The couple felt it was a cause worth coming home for.
From the (Raleigh) News & Observer
Durham, Atlanta Companies Partner
The search for medicines that counter the effects of the stress hormone adrenaline has led a tiny Durham startup to a deal that could be worth more than $200 million.
From the (Raleigh) News & Observer
Community Watch
- Stiefel Laboratories, the world’s largest privately held pharmaceutical company specializing in dermatology products, is buying Princeton, N.J.-based Barrier Therapeutics. Stiefel is headquartered in Coral Gables, Fla., but operates its research and development facility in Research Triangle Park. The $148 million deal is expected to close in the third quarter. More
- Burlington-based Laboratory Corporation of America has begun selling an ovarian cancer screening product, OvaSure, a blood test using six biomarkers that can detect early-stage disease in high-risk women. More
Wilmington-based AAIPharma won an achievement award from the North Carolina Department of Labor for reaching nine million work hours without a lost workday injury. The span was from August 4, 1999, through February 21, 2008.
- Tom Sloan, a long-time healthcare start-up investor who served for three decades as president and chairman of Southern Optical Company, has been appointed to the board of directors of Piedmont Pharmaceuticals in Greensboro, filling a seat vacated by Lanty Smith, who was recently appointed chairman and interim CEO of Wachovia Corp.
Please send Community Watch items to Jim Shamp.
September 9-10
BioPharm America 2008
(Atlanta)
September 21-24
AdvaMed 2008
(Washington, D.C.)
October 28
Charlotte Biotechnology Conference
(Charlotte)
December 4-5
SE Bio Investor Forum
(Palm Beach, Fla.)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, July 3, 2008. For the latest headlines from North Carolina's biotechnology industry, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.